See also this year's filing and all EDGAR filings for this company.
PDF Report 0001740547_2020_Urovant_Sciences_Ltd.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001740547, Urovant Sciences Ltd
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,510,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 923,000 |
| 3 | remainder_Assets | 688,000 |
| 4 | LiabilitiesCurrent | 11,817,000 |
| 5 | LiabilitiesNoncurrent | 13,534,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,585,000 |
| 9 | ResearchAndDevelopmentExpense | 92,198,000 |
| 10 | remainder_Expenses | 47,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -516,000 |
| 13 | remainder_ComprehensiveNetIncome | 262,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,121,000 |
| 1 | Liabilities | 25,351,000 |
| 2 | Expenses | 110,830,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 74,770,000 |
| 5 | NetIncome | -111,346,000 |
| 6 | ComprehensiveNetIncome | -111,215,000 |
| 7 | BaseVar | 118,540,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.825 |
| 9 | EconomicCapitalRatio | 2.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
